Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000420025 | SCV000511179 | likely benign | not provided | 2016-10-27 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV001084340 | SCV000652971 | benign | Acroosteolysis-keloid-like lesions-premature aging syndrome; Basal ganglia calcification, idiopathic, 4; Infantile myofibromatosis; Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV001199248 | SCV001370298 | benign | Basal ganglia calcification, idiopathic, 4 | 2019-04-08 | criteria provided, single submitter | clinical testing | This variant was classified as: Benign. The following ACMG criteria were applied in classifying this variant: BS1,BS2. |
Gene |
RCV000420025 | SCV001960682 | benign | not provided | 2019-04-02 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316523 | SCV004016554 | benign | Myeloproliferative disorder, chronic, with eosinophilia | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000420025 | SCV004157354 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | PDGFRB: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV000420025 | SCV005223210 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001796032 | SCV002035251 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000420025 | SCV002035770 | likely benign | not provided | no assertion criteria provided | clinical testing |